|
Index of reports
> Cases resulting in hospitalization (165)
Below is the selection of adverse event reports related to Aldactone (Spironolactone) that includes cases resulting in hospitalization.
Reports 1 - 25 of 165 Next >>
Adverse event in receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from France on 2007-10-29
Patient:
Adverse reactions / side effects: Blood Urea Increased, Overdose, Drug Interaction, Blood Creatinine Increased, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Ramipril
Dosage: 2.5 mg, bid
Administration route: Oral
End date: 2007-09-08
Lasix
Dosage: 40 mg, bid
Administration route: Oral
End date: 2007-09-08
Aldactone
Dosage: 250 mg, qd
Administration route: Oral
End date: 2007-09-08
Other drugs received by patient: Ditropan / 00538901 /; Escitalopram; Ogast; Previscan / 00789001 /; Lyrica; Havlane; Novomix / 01475801 /
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-10-26
Patient: female
Adverse reactions / side effects: Syncope, Dyspnoea, Injection Site Haematoma, Coagulopathy, Oedema, Arterial Occlusive Disease, Pulmonary Oedema, Depression, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Administration route: Oral
Start date: 2004-01-01
End date: 2006-01-01
Caduet
Dosage: text:10mg/5mg;20mg/10mg
Administration route: Oral
Indication: Hypertension
Aldactone
Administration route: Oral
Indication: Hypertension
Olmetec
Administration route: Oral
Indication: Hypertension
Coristina D
Administration route: Oral
Indication: Influenza
Insulin
Indication: Diabetes Mellitus
Start date: 2004-11-01
Novonorm
Adverse event in male receiving Aldactone (Spironolactone)
Reported by a individual with unspecified qualification from United States on 2007-10-24
Patient: male, weighing 95.0 kg (209.0 pounds)
Adverse reactions / side effects: Renal Failure, Diabetes Mellitus, Hypotension, Cardiac Failure Congestive
Adverse event resulted in: hospitalization
Suspect drug(s):
Bibr 1048 (Dabigatran Etexilate) (Blind)
Administration route: Oral
Indication: Cerebrovascular Accident Prophylaxis
Bibr 1048 (Dabigatran Etexilate) (Blind)
Indication: Thrombosis Prophylaxis
Lasix
Administration route: Oral
Indication: Hypertension
Lasix
Indication: Cardiac Failure Congestive
Vasotec
Administration route: Oral
Indication: Hypertension
Vasotec
Indication: Cardiac Failure Congestive
Digoxin
Administration route: Oral
Indication: Ischaemic Cardiomyopathy
Aldactone
Administration route: Oral
Indication: Hypertension
Other drugs received by patient: Levemir; Digitek
Adverse event in male receiving Aldactone (Spironolactone)
Reported by a physician from United States on 2007-10-23
Patient: male
Adverse reactions / side effects: Renal Failure, Hypotension, Cardiac Failure Congestive
Adverse event resulted in: hospitalization
Suspect drug(s):
Aldactone
Dosage: daily dose:25mg-freq:frequency: 25mg, qod
Administration route: Oral
Indication: Hypertension
Blinded Spironolactone
Administration route: Oral
Indication: Prophylaxis
Blinded Spironolactone
Indication: Embolism
Lasix
Dosage: daily dose:40mg
Administration route: Oral
Indication: Hypertension
Lasix
Indication: Cardiac Failure Congestive
Vasotec
Dosage: daily dose:10mg
Administration route: Oral
Indication: Hypertension
Vasotec
Indication: Cardiac Failure Congestive
Digoxin
Dosage: daily dose:.125mg
Administration route: Oral
Indication: Ischaemic Cardiomyopathy
Adverse event in 52 year old male receiving Aldactone (Spironolactone)
Reported by a health professional (non-physician/pharmacist) from France on 2007-10-23
Patient: 52 year old male
Adverse reactions / side effects: Phlebitis, Pulmonary Embolism
Adverse event resulted in: hospitalization
Suspect drug(s):
Aldactone
Administration route: Oral
Indication: Nephrotic Syndrome
Thalidomide
Administration route: Oral
Indication: Multiple Myeloma
Lasix
Administration route: Oral
Indication: Nephrotic Syndrome
Triatec
Administration route: Oral
Indication: Nephrotic Syndrome
Other drugs received by patient: Alkeran; Dexamethasone
Adverse event in 65 year old male receiving Aldactone (Spironolactone)
Reported by a physician from United States on 2007-10-18
Patient: 65 year old male
Adverse reactions / side effects: Renal Failure, Hypotension
Adverse event resulted in: hospitalization
Suspect drug(s):
Lasix
Administration route: Oral
Indication: Hypertension
Lasix
Administration route: Oral
Aldactone
Administration route: Oral
Indication: Hypertension
Antithrombotic Agents
Dosage: dose: unk
Antithrombotic Agents
Dosage: dose: unk
Vasotec / 00935901 /
Administration route: Oral
Indication: Hypertension
Vasotec / 00935901 /
Administration route: Oral
Digoxin
Administration route: Oral
Adverse event in 71 year old male receiving Aldactone (Spironolactone)
Reported by a individual with unspecified qualification on 2007-10-17
Patient: 71 year old male
Adverse reactions / side effects: Drug Interaction, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Ramipril
Administration route: Oral
End date: 2007-09-08
Lasix
Administration route: Oral
End date: 2007-09-08
Aldactone
Administration route: Oral
End date: 2007-09-08
Other drugs received by patient: Ditropan; Escitalopram; Ogast; Previscan / 00789001 /; Lyrica; Havlane; Novomix / 01475801 /
Adverse event in receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from France on 2007-10-17
Patient:
Adverse reactions / side effects: Hypotension, Rectal Haemorrhage, Gastric Ulcer
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 1 u, qd
Administration route: Oral
Indication: Hypertension
Lasix
Dosage: 40 mg, qd
Administration route: Oral
Indication: Cardiac Failure
Previscan / 00789001 /
Dosage: 25 mg, qd
Administration route: Oral
Indication: Thrombosis
End date: 2006-10-13
Previscan / 00789001 /
Start date: 2006-10-15
Aldactone
Dosage: 1 u film-coated tablet
Administration route: Oral
Indication: Cardiac Failure
Elisor
Dosage: 1 u tablet,qd
Administration route: Oral
Indication: Hypercholesterolaemia
Adverse event in male receiving Aldactone (Spironolactone)
Reported by a health professional (non-physician/pharmacist) from France on 2007-10-16
Patient: male
Adverse reactions / side effects: Malaise, Hyperkalaemia, Bundle Branch Block
Adverse event resulted in: hospitalization
Suspect drug(s):
Atacand
Administration route: Oral
Aldactone
Administration route: Oral
End date: 2006-10-17
Lasix
Administration route: Oral
Other drugs received by patient: Tahor; Metformin
Adverse event in 70 year old male receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-10-12
Patient: 70 year old male
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Lansoprazole
Administration route: Oral
Start date: 2007-05-11
End date: 2007-06-13
Lasix
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-05-11
End date: 2007-06-13
Artist
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-05-15
End date: 2007-06-13
Renivace
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-05-06
End date: 2007-06-13
Amlodipine
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-05-09
End date: 2007-06-13
Magmit
Administration route: Oral
Indication: Constipation
Start date: 2007-05-09
End date: 2007-06-13
Aldactone
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-05-14
End date: 2007-06-13
Other drugs received by patient: Aspirin; Ticlopidine HCL
Adverse event in 62 year old female receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-10-12
Patient: 62 year old female
Adverse reactions / side effects: Pulmonary Embolism, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone (Spironolactone)
Other drugs received by patient: NU Lotan; Mercazole
Adverse event in 72 year old male receiving Aldactone (Spironolactone)
Reported by a individual with unspecified qualification on 2007-10-11
Patient: 72 year old male
Adverse reactions / side effects: Malaise, Hyperkalaemia, Bundle Branch Block
Adverse event resulted in: hospitalization
Suspect drug(s):
Lasix
Administration route: Oral
Aldactone
Administration route: Oral
End date: 2006-10-17
Atacand
Administration route: Oral
Other drugs received by patient: Tahor; Metformin HCL; Amlor
Adverse event in receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from France on 2007-10-05
Patient:
Adverse reactions / side effects: Phlebitis, Pulmonary Embolism, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 1.25 mg, qd
Administration route: Oral
Indication: Nephrotic Syndrome
Lasix
Dosage: unk, qd
Administration route: Oral
Indication: Nephrotic Syndrome
Thalidomide
Dosage: 200 mg, qd
Administration route: Oral
Indication: Multiple Myeloma
Aldactone
Dosage: 75 mg, qd
Administration route: Oral
Indication: Nephrotic Syndrome
Other drugs received by patient: Alkeran; Dexamethasone 0.5mg TAB; Previscan / 00789001 /
Adverse event in 58 year old male receiving Aldactone (Spironolactone)
Reported by a individual with unspecified qualification on 2007-10-04
Patient: 58 year old male
Adverse reactions / side effects: Rectal Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Ramipril
Administration route: Oral
Lasix
Administration route: Oral
Indication: Cardiac Failure
Previscan / 00789001 /
Administration route: Oral
Indication: Thrombosis
End date: 2006-10-13
Aldactone
Administration route: Oral
Indication: Cardiac Failure
Elisor
Administration route: Oral
Adverse event in 53 year old male receiving Aldactone (Spironolactone)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-04
Patient: 53 year old male
Adverse reactions / side effects: Hepatic Encephalopathy, Infection
Adverse event resulted in: hospitalization
Suspect drug(s):
Avlocardyl LP
Administration route: Oral
Actiskenan
Dosage: not provided
Administration route: Oral
Start date: 2006-07-05
End date: 2006-07-10
Stablon
Administration route: Oral
Indication: Depression
Aldactone
Administration route: Oral
Pentoxifylline
Administration route: Oral
Indication: Cirrhosis Alcoholic
Start date: 2006-01-06
End date: 2006-07-13
Dafalgan Codeine
Administration route: Oral
Start date: 2006-07-05
End date: 2006-07-10
Other drugs received by patient: Clamoxyl; Lantus; Duphalac; Vitamin B1 and B6; Novorapid
Adverse event in receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from France on 2007-07-26
Patient:
Adverse reactions / side effects: LOW Cardiac Output Syndrome, Vomiting, Dyspnoea, Hyperkalaemia, Drug Interaction, Haemodialysis, Cardiac Failure, Renal Tubular Necrosis, Hypoperfusion, Blood Creatinine Increased, Renal Failure Acute, Anuria
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Administration route: Oral
End date: 2007-05-08
Lasilix / 00032601 /
Administration route: Oral
End date: 2007-05-08
Cordarone / 00133102 /
Dosage: 200 mg, unk
Administration route: Oral
Aldactone
Administration route: Oral
End date: 2007-05-08
Celebrex
Administration route: Oral
Indication: Pain in Extremity
Other drugs received by patient: Previscan / 00789001 /
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-07-24
Patient: female, weighing 61.5 kg (135.3 pounds)
Adverse reactions / side effects: Hyperkalaemia, Bradyarrhythmia, Hypotension
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-02-01
End date: 2007-06-27
Micardis
Indication: Hypertension
Start date: 2005-01-01
End date: 2007-06-27
Other drugs received by patient: Amaryl; Basen; Aspirin; Lasix; Artist; Frandol; Magnesium Oxide
Adverse event in 77 year old male receiving Aldactone (Spironolactone)
Reported by a physician from Australia on 2007-07-23
Patient: 77 year old male, weighing 104.0 kg (228.8 pounds)
Adverse reactions / side effects: Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Lasix
Indication: Pleural Effusion
Aldactone
Indication: Pleural Effusion
Other drugs received by patient: Lipidil; Warfarin Sodium; Gemfibrozil; Atorvastatin Calcium; Allopurinol; Telmisartan; Trandolapril; Verapamil; Prazosin HCL
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-07-23
Patient: female, weighing 53.0 kg (116.6 pounds)
Adverse reactions / side effects: Dizziness
Adverse event resulted in: hospitalization
Suspect drug(s):
Candesartan Cilexetil
Administration route: Oral
Indication: Cardiac Failure Chronic
Start date: 2007-04-28
End date: 2007-05-07
Candesartan Cilexetil
Administration route: Oral
Start date: 2007-05-08
Lasix
Administration route: Oral
Indication: Cardiac Failure Chronic
Aldactone
Administration route: Oral
Indication: Cardiac Failure Chronic
Other drugs received by patient: Halcion; Digosin; Warfarin Sodium; Persantin; Mucosta; Kalgut; Sennoside; Merislon; Cephadol; Aphtasolon
Adverse event in 70 year old male receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-07-20
Patient: 70 year old male
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Lansoprazole
Administration route: Oral
Start date: 2007-05-11
End date: 2007-06-13
Lasix
Administration route: Oral
Start date: 2007-05-11
End date: 2007-06-13
Artist
Administration route: Oral
Start date: 2007-05-15
End date: 2007-06-13
Enalapril Maleate
Administration route: Oral
Start date: 2007-05-06
End date: 2007-06-13
Amlodipine
Administration route: Oral
Start date: 2007-05-09
End date: 2007-06-13
Magmit
Administration route: Oral
Indication: Constipation
Start date: 2007-05-09
End date: 2007-06-13
Aldactone
Administration route: Oral
Start date: 2007-05-14
End date: 2007-06-13
Other drugs received by patient: Bayaspirin; Ticlopidine HCL
Adverse event in 79 year old male receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-07-19
Patient: 79 year old male
Adverse reactions / side effects: Pancreatitis, Pyrexia, Somnolence, Eye Disorder, Asthenia, Immobile
Adverse event resulted in: hospitalization
Suspect drug(s):
Lasix
Dosage: dose: 2 tab
Administration route: Oral
Indication: Swelling
Start date: 2006-07-01
End date: 2007-02-01
Lasix
Start date: 2007-05-01
End date: 2007-06-01
Aldactone
Dosage: dose: 2 tab
Administration route: Oral
Indication: Swelling
Adverse event in male receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-07-18
Patient: male
Adverse reactions / side effects: Urinary Tract Infection, Pancreatitis, Gait Disturbance, Asthenia, Constipation, Hypersomnia, Shock
Adverse event resulted in: hospitalization
Suspect drug(s):
Aldactone
Administration route: Oral
Lasix
Other drugs received by patient: Plamet; Pravachol; Pantoprazole Sodium; Carvedilol; Lactulose
Adverse event in male receiving Aldactone (Spironolactone)
Reported by a health professional (non-physician/pharmacist) from France on 2007-07-17
Patient: male
Adverse reactions / side effects: Hyperkalaemia, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Aldactone
Administration route: Oral
Celebrex
Indication: Pain in Extremity
Lasix
Administration route: Oral
Triatec
Administration route: Oral
Cordarone
Other drugs received by patient: Fluindione
Adverse event in 70 year old male receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-07-16
Patient: 70 year old male
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Lansoprazole
Administration route: Oral
Start date: 2007-05-11
End date: 2007-06-13
Lasix
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-05-11
End date: 2007-06-13
Artist
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-05-15
End date: 2007-06-13
Renivace
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-05-06
End date: 2007-06-13
Amlodin
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-05-09
End date: 2007-06-13
Magmit
Administration route: Oral
Indication: Constipation
Start date: 2007-05-09
End date: 2007-06-13
Aldactone
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-05-14
End date: 2007-06-13
Other drugs received by patient: Aspirin; Ticlopidine HCL
Adverse event in male receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-07-16
Patient: male
Adverse reactions / side effects: Toxic Epidermal Necrolysis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone
Dosage: daily dose:50mg-freq:frequency: bid
Indication: Oedema
Start date: 2007-05-08
End date: 2007-05-21
Soldactone
Dosage: daily dose:200mg
Indication: Oedema
Start date: 2007-04-25
End date: 2007-05-07
Soldactone
Indication: Ascites
Other drugs received by patient: Lasix; Pariet; Magnesium Oxide; Livact; Lactulose
Page 1 Next >>
|
